Bain Capital Life Sciences

New York
Firm Location:New York • Massachusetts • New York, New York • Boston, Massachusetts • San Francisco Bay Area • New York City
Bain Capital Life Sciences Team
Photo of Brad Balter, Vice President at Bain Capital Life Sciences
Brad Balter
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Boston / New England (Other Lists), Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed)
Photo of Jonah Cashdan, Vice President at Bain Capital Life Sciences
Jonah Cashdan
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY)
Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in New York City (Other Lists)
Photo of Michael Cooney, Associate at Bain Capital Life Sciences
Michael Cooney
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series B), Investors in Boston / New England (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Seed)
Photo of Jennie Daisak, Associate at Bain Capital Life Sciences
Jennie Daisak
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York City
Photo of Nicholas Downing, Principal at Bain Capital Life Sciences
Nicholas Downing
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
DF
Drew Field
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY)
Photo of Dylan Goldstein, Associate at Bain Capital Life Sciences
Dylan Goldstein
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Photo of Evan Greif, Associate at Bain Capital Life Sciences
Evan Greif
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Photo of Andrew Hack, Managing Director at Bain Capital Life Sciences
Andrew Hack
Bain Capital Life Sciences·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Medical Devices (Series B), Investors in Diagnostics (Series B), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Seed), Investors in Diagnostics (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Series B), Investors in BioTech (Series B), Investors in Diagnostics (Seed), Investors in Pharmaceuticals (Series B), Investors in Boston / New England (Other Lists), Investors in BioTech (Series A), Investors in Medical Devices (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed)
Photo of Adam Koppel, Managing Director at Bain Capital Life Sciences
Adam Koppel
Bain Capital Life Sciences·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston / New England, Investors in Boston (MA), Investors in Massachusetts
Photo of Benjamin Lund, Principal at Bain Capital Life Sciences
Benjamin Lund
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Photo of Ritika Mahal, Vice President at Bain Capital Life Sciences
Ritika Mahal
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Photo of Tapan Maniar, Bain Capital Life Sciences
Tapan Maniar
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in SF Bay Area (CA)
Photo of Jeffrey Schwartz, Managing Director at Bain Capital Life Sciences
Jeffrey Schwartz
Bain Capital Life Sciences·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Photo of Ricky Lijing Sun, Managing Director at Bain Capital Life Sciences
Ricky Lijing Sun
Bain Capital Life Sciences·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Boston / New England (Other Lists)
Photo of Harris Weber, Vice President at Bain Capital Life Sciences
Harris Weber
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York
Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed)
Photo of Julie Yang, Associate at Bain Capital Life Sciences
Julie Yang
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Boston / New England (Other Lists), Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed)
Photo of Amir Zamani, Principal at Bain Capital Life Sciences
Amir Zamani
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Boston / New England (Other Lists), Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed)